LOS ANGELES, CA — (Marketwired) — 09/25/14 — (OTCQB: MMRF), through its wholly owned subsidiary MyMedicalRecords, Inc. (collectively, “MMR”), today announced that the Mexican Institute of Industrial Property (IMPI) has issued an official Notice of Allowance for Mexican Patent Application No. MX/a/2012/001633. The allowed patent application is directed toward computer systems for managing and communicating with healthcare providers. Of particular significance is an emergency access feature that allows emergency responders or healthcare providers to have access to important health information in a user–s Personal Health Record account in the event of an emergency. MMR has additional patent applications pending relating to the emergency access feature in the U.S. and elsewhere throughout the world.
According to MMRGlobal CEO Robert H. Lorsch, “Giving patients the ability to communicate with first responders and medical personnel in the event of an emergency is a significant feature and benefit of MyMedicalRecords. The feature allows users to selectively provide access to lifesaving information without compromising the privacy of a medical record. “
A recent study entitled “Going Mobile: How Mobile Personal Health Records Can Improve Health Care During Emergencies,” further validates the benefits of having comprehensive emergency access on a PHR .
With products available in both English and Spanish, MMRGlobal is a leading provider of secure and easy-to-use Personal Health Records through its PHR and MMRPro document management and imaging systems for . MMR also provides , which provides an online site to securely store important legal, financial, insurance and other important documents, as well as medical and personal health information. MMR currently has 13 issued U.S. health IT patents including U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; 8,321,240; 8,498,883; 8,626,532, 8,645,161; 8,725,537; 8,768,725 and 8,775,212, as well as additional applications and continuation applications involving inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. In addition to the U.S., MMR currently has patents issued, pending and/or applied for in 11 other countries or regional authorities including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, China, South Korea, Israel and Europe.
MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records (“PHRs”) and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user–s account. MMR–s professional offering, , is designed to give physicians– offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId/Specifid vaccine clinical trials for the treatment of B-Cell Non-Hodgkin–s lymphoma. To learn more about MMRGlobal, Inc. visit . View demos and video tutorials of MMR–s products and services at . Follow us at and .
All statements in this release that are not strictly historical facts are “forward-looking statements.” Such forward-looking statements are based on MMR–s current assumptions, beliefs and expectations, and involve risks, uncertainties and other factors that may cause MMR–s actual results to be materially different from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words such as “expect,” “plan,” “possibility,” “offer,” “if,” “negotiate,” “when,” “believe,” “will,” “estimate,” “continue,” and similar expressions. Risks, uncertainties, and other factors that could cause or contribute to such differences include, but are not limited to: ongoing and future intellectual property enforcement actions; the ability to successfully litigate or settle claims of patent infringement; MMR–s ability to develop, license and monetize its patents in the portfolio for both MMR–s health IT and biotechnology IP assets in the U.S. and internationally; reliance upon the successful operations of its business partners in selling MMR–s products and services, the timing of milestone payments in connection with licensing its IP; MMR–s ability to obtain necessary financing, generate sufficient cash flow, and maintain appropriate indebtedness; and the increasing development of market competition in the area of electronic records in clinical trials. These factors and others are described in more detail in MMR–s public filings with the Securities and Exchange Commission, including the risks discussed in the “Risk Factors” section in MMR–s Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of these reports can be found on MMR–s website () under the heading “Investor Relations.” MMR is providing this information as of the date of this release and, except as required by law, does not undertake any obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise.
Michael Selsman
Public Communications Co.
(310) 922-7033
You must be logged in to post a comment Login